Please find below the final agenda.
The webinar will focus on exploring the impact that COVID-19 has had on remote patient monitoring for children taking parting in clinical trials. We will be joined by clinicians who experienced first hand the use of technology during the pandemic, experts with patient advocacy, and technology background. The FDA will present opportunities that this pandemic may have to offer with the use of technology.
Although many clinical studies were halted during the global pandemic, more companies and clinicians are considering patients remote monitoring as a solution to prioritise patients safety in these uncertain times.
Welcome and Introduction (5 min) :
Cécile Ollivier, Chief Innovation Officer, Aparito
Moderator and Introduction of Presenters (5 min) :
Dr. Gary Noel, Chief Medical Officer, Institute for Advanced Clinical Trials for Children
1. Presentation by MICRYN (10 min) :
Breanne Stewart, University of Alberta
2. Presentation by I-ACT for Children (10 min) :
Dr. Emily C. de los Reyes and Shelli Farley, Nationwide Children’s Hospital
3. Presentation by C4C (10 min) :
Dr. Marina Vivarelli, Ospedale Pediatrico Bambino Gesù
4. How technology can address the needs of paediatric research (10 min) :
Dr. Elin Haf Davies, CEO Aparito
5. FDA perspective (10 min) :
Dr John Alexander (Division of Pediatric and Maternal Health, FDA)
6. Moderator led discussion (30 min)
Dr. Gary Noel, CMO, Institute for Advanced Clinical Trials for Children
Discussion panelist: Breanne Stewart (MICRYN), Dr. Emily C. de los Reyes and Shelli Farley (I-ACT), Dr. Marina Vivarelli and Mark Turner (C4C), Elin Haf Davies (Aparito) and John Alexander (FDA)
Final remarks by moderators (5 min)